Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.70 |
| ▸ | ATM | Q13315 | 1/20 | 0.70 |
| ▸ | MAPT | P10636 | 4/20 | 0.63 |
| ▸ | RAB9A | P51151 | 4/20 | 0.63 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.63 |
| ▸ | NPC1 | O15118 | 3/20 | 0.63 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.63 |
| ▸ | TP53 | P04637 | 1/20 | 0.63 |
| ▸ | PKM | P14618 | 1/20 | 0.63 |
| ▸ | HPGD | P15428 | 1/20 | 0.63 |
| ▸ | GAA | P10253 | 1/20 | 0.59 |
| ▸ | STING1 | Q86WV6 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 3/20 | 0.45 |
| ▸ | NQO2 | P16083 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30423168 | 1.00 | ALOX15 (0.70) | ALOX15ATMMAPTRAB9ASMN1; SMN2 | |
| SCHEMBL9310828 | 0.89 | GAA (0.66) | ALOX15ATMMAPTRAB9ASMN1; SMN2 | |
| SCHEMBL18618286 | 0.89 | ALOX15 (0.66) | ALOX15ATMMAPTRAB9ASMN1; SMN2 | |
| SCHEMBL18201941 | 0.86 | ALOX15 (0.55) | ALOX15ATMMAPTRAB9ASMN1; SMN2 | |
| SCHEMBL18587907 | 0.85 | ALOX15 (0.62) | ALOX15ATMMAPTRAB9ASMN1; SMN2 | |
| SCHEMBL15839256 | 0.85 | ALOX15 (0.58) | ALOX15ATMMAPTRAB9ASMN1; SMN2 | |
| SCHEMBL14970154 | 0.85 | ALOX15 (0.62) | ALOX15ATMMAPTRAB9ASMN1; SMN2 | |
| SCHEMBL16787513 | 0.85 | ALOX15 (0.62) | ALOX15ATMMAPTRAB9ASMN1; SMN2 | |
| SCHEMBL9434842 | 0.85 | ALOX15 (0.58) | ALOX15ATMMAPTRAB9ASMN1; SMN2 | |
| SCHEMBL1914041 | 0.85 | ALOX15 (0.62) | ALOX15ATMMAPTRAB9ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118355041-A | Method for underwater bonding | 汉高股份有限及两合公司 | 2024-07-16 | — | — | CN | claimed |
| EP-3464446-B1 | TWO-PART CYANOACRYLATE CURABLE ADHESIVE SYSTEM | Henkel IP & Holding GmbH (DE) | 2021-06-23 | — | — | EP | claimed |
| CN-109476874-B | Two-part cyanoacrylate curable adhesive systems | 汉高知识产权控股有限责任公司 | 2021-04-16 | — | — | CN | claimed |
| EP-3464446-A1 | TWO-PART CYANOACRYLATE CURABLE ADHESIVE SYSTEM | Henkel IP & Holding GmbH (DE) | 2019-04-10 | — | — | EP | claimed |
| CN-109476874-A | Bi-component cyanoacrylate curable adhesive system | 汉高知识产权控股有限责任公司 | 2019-03-15 | — | — | CN | claimed |
| US-10100235-B2 | Two-part cyanoacrylate curable adhesive system | Henkel IP & Holding GmbH (DE) | 2018-10-16 | — | — | US | claimed |
| WO-2017202698-A1 | TWO-PART CYANOACRYLATE CURABLE ADHESIVE SYSTEM | Henkel IP & Holding GmbH (DE) | 2017-11-30 | — | — | WO | claimed |
| US-20170335151-A1 | TWO-PART CYANOACRYLATE CURABLE ADHESIVE SYSTEM | HENKEL AG & CO. KGAA (DE) | 2017-11-23 | — | — | US | claimed |
| EP-2346956-A1 | ACTIVATORS FOR TWO PART CYANOACRYLATE ADHESIVES | Loctite (R & D) Limited (IE) | 2011-07-27 | — | — | EP | claimed |
| WO-2010046412-A1 | ACTIVATORS FOR TWO PART CYANOACRYLATE ADHESIVES | LOCTITE (R & D) LIMITED (IE) | 2010-04-29 | — | — | WO | claimed |
| EP-1087952-B1 | BENZAZOLE COMPOUNDS AND THEIR USE | NOVARTIS AG (CH) | 2004-06-02 | — | — | EP | claimed |
| US-6410578-B1 | INSECTICIDE, MITICIES, PESTICIDE | NOVARTIS ANIMAL HEALTH US, INC. | 2002-06-25 | — | — | US | claimed |
| EP-1087952-A1 | BENZAZOLE COMPOUNDS AND THEIR USE | Novartis AG (CH) | 2001-04-04 | — | — | EP | claimed |
| WO-1999065886-A1 | BENZAZOLE COMPOUNDS AND THEIR USE | NOVARTIS AG (CH) | 1999-12-23 | — | — | WO | claimed |
| US-20240318052-A1 | METHOD OF UNDERWATER BONDING | HENKEL AG & CO KGAA (DE) | 2024-09-26 | — | — | US | disclosed |
| US-11815448-B2 | Method, reagent, and chip for measuring analyte concentration in specimen | TERUMO KABUSHIKI KAISHA (JP) | 2023-11-14 | — | — | US | disclosed |
| US-11739083-B2 | Disposable sensor chip with reagent including 2-substituted benzothiazolyl-3-substituted phenyl-5-substituted sulfonated phenyl-2H-tetrazolium salt | TERUMO KABUSHIKI KAISHA (JP) | 2023-08-29 | — | — | US | disclosed |
| WO-1999065886-A1 | BENZAZOLE COMPOUNDS AND THEIR USE | NOVARTIS AG (CH) | 1999-12-23 | — | — | WO | disclosed |
| WO-1998000756-A1 | SILVER HALIDE EMULSIONS | POLAROID CORPORATION (US) | 1998-01-08 | — | — | WO | disclosed |
| US-5601963-A | SILVER GRAINS HAVE BEEN SPECTRALLY SENSITIZED TO NEAR INFRARED RADIATION AT WAVELENGTHS ABOVE 700 NM WITH A PARTICULAR CLASS OF CYANINE DYES | POLAROID CORPORATION (US) | 1997-02-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11815448-B2 | Method, reagent, and chip for measuring analyte concentration in specimen | STUB1, MPO, ALDH1A2 | ALOX15 1578/4885ATM 3923/4885MAPT 3928/4885 |
| US-11739083-B2 | Disposable sensor chip with reagent including 2-substituted benzothiazolyl-3-substituted phenyl-5-substituted sulfonated phenyl-2H-tetrazolium salt | STUB1, BTK, TST | ALOX15 3458/4885ATM 1875/4885MAPT 1351/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.